{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:54:17Z","timestamp":1772132057306,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.transproceed.2022.02.027","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T01:55:20Z","timestamp":1647309320000},"page":"1446-1454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association Between Total Cell Free DNA and SARS-CoV-2 In Kidney Transplant Patients: A Preliminary Study"],"prefix":"10.1016","volume":"54","author":[{"suffix":"Jr","given":"Jose Otto","family":"Reusing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jongwon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amishi","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katya","family":"Brossart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson Koyen","family":"Malashevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Fehringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roseann","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Billings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Tabriziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary P.","family":"Demko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev K.","family":"Akkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"David-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.02.027_bib0001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQITM) conference","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0002","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1399-0012.2011.01546.x","article-title":"Acute kidney injury as defined by the RIFLE criteria is a risk factor for kidney transplant graft failure","volume":"26","author":"Nakamura","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0003","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.ijt.2014.01.011","article-title":"Post renal transplant acute kidney injury","volume":"8","author":"Mittal","year":"2014","journal-title":"Indian J Transplant"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0004","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0005","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0006","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.trre.2013.04.003","article-title":"The impact of calcineurin inhibitors on graft survival","volume":"27","author":"Rush","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0008","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.kint.2019.01.041","article-title":"An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients","volume":"96","author":"Sommerer","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0009","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41581-020-00340-z","article-title":"The impact of COVID-19 on kidney transplantation","volume":"16","author":"Alasfar","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0010","first-page":"411","article-title":"Cell-free DNA tissues-of-origin by methylation profiling reveals significant cell, tissue and organ-specific injury related to COVID-19 severity","volume":"2","author":"Cheng","year":"2021","journal-title":"Med (N Y)"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0011","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1681\/ASN.2020050639","article-title":"COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes","volume":"31","author":"Elias","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0012","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0013","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1681\/ASN.2020040509","article-title":"AKI in hospitalized patients with and without COVID-19: a comparison study","volume":"31","author":"Fisher","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0014","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1111\/ajt.16185","article-title":"COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","article-title":"Acute kidney injury in patients hospitalized with COVID-19","volume":"98","author":"Hirsch","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0016","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0017","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ekir.2020.04.001","article-title":"Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy","volume":"5","author":"Alberici","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcm8010019","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR","volume":"8","author":"Sigdel","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0019","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/TP.0000000000002482","article-title":"Donor-specific cell-free DNA as a biomarker in solid organ transplantation. A systematic review","volume":"103","author":"Knight","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0021","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000469669","article-title":"Serum creatinine: not so simple!","volume":"136","author":"Delanaye","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0022","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1097\/TP.0000000000002665","article-title":"Analytical validation of a single-nucleotide polymorphism-based donor-derived cell-free DNA assay for detecting rejection in kidney transplant patients","volume":"103","author":"Altug","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0024","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0025","unstructured":"WHO R&D Blueprint: novel Coronavirus: COVID-19 Therapeutic Trial Synopsis, <https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdf>; [accessed 01.09.20]."},{"key":"10.1016\/j.transproceed.2022.02.027_bib0026","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/j.transproceed.2021.09.027","article-title":"Incorporation of donor-derived cell-free DNA into clinical practice for renal allograft management","volume":"53","author":"Qazi","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0027","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3390\/v6072723","article-title":"Increased plasma cell-free DNA level during HTNV infection: correlation with disease severity and virus load","volume":"6","author":"Yi","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0028","doi-asserted-by":"crossref","first-page":"18738","DOI":"10.1073\/pnas.1906320116","article-title":"A cell-free DNA metagenomic sequencing assay that integrates the host injury response to infection","volume":"116","author":"Cheng","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0029","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/infdis\/jiaa241","article-title":"Circulating rather than alveolar extracellular deoxyribonucleic acid levels predict outcomes in influenza","volume":"222","author":"Zhang","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0030","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1097\/TXD.0000000000001145","article-title":"Extremely high cell-free DNA levels observed in renal allograft patient with SARS-CoV-2 infection","volume":"7","author":"Bunnapradist","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.08.041","article-title":"Detection of severe acute respiratory syndrome coronavirus 2 in nasopharynx according to clinical phenotype of affected patients","volume":"26","author":"Valent","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0032","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jinf.2020.03.053","article-title":"Duration for carrying SARS-CoV-2 in COVID-19 patients","volume":"81","author":"Du","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0033","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.eururo.2020.03.039","article-title":"Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China","volume":"77","author":"Zhu","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0034","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0035","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/infdis\/jiaa446","article-title":"Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy","volume":"222","author":"Helleberg","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0036","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.krcp.2015.09.002","article-title":"Effect of blood pressure and glycemic control on the plasma cell-free DNA in hemodialysis patients","volume":"34","author":"Jeong","year":"2015","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0037","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study","volume":"19","author":"Oellerich","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0038","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ajt.15142","article-title":"Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction","volume":"19","author":"Whitlam","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.02.027_bib0039","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1681\/ASN.2021050645","article-title":"Using both the fraction and quantity of donor-derived cell-free dna to detect kidney allograft rejection","volume":"32","author":"Bunnapradist","year":"2021","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522001932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522001932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:41:46Z","timestamp":1758577306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134522001932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0041134522001932"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.02.027","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Total Cell Free DNA and SARS-CoV-2 In Kidney Transplant Patients: A Preliminary Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}